Sarampote CS, Efron LA, Robb AS et al. (2002), Can stimulant rebound mimic pediatric bipolar disorder? J Child Adolesc Psychopharmacol 12(1):63-67.
Stigler KA, Desmond LA, Posey DJ et al. (2004), A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J Child Adolesc Psychopharmacol 14(1):49-56.
Tan M, Appleton R (2005), Attention deficit and hyperactivity disorder, methylphenidate(Drug information on methylphenidate), and epilepsy. Arch Dis Child 90(1):57-59.
Tossell JW, Greenstein DK, Davidson AL et al. (2004), Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series. J Child Adolesc Psychopharmacol 14(3):448-454.
Vitiello B, Jensen PS (1995), Developmental perspectives in pediatric psychopharmacology. Psychopharmacol Bull 31(1):75-81.
Wilens TE, Biederman J, Kwon A et al. (2003), A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol 13(2):143-152.
Young JG (1981), Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action. J Dev Behav Pediatr 2(2):35-38.
